Header Logo

Connection

Barry Maron to Death, Sudden, Cardiac

Back to Details
This is a "connection" page, showing publications Barry Maron has written about Death, Sudden, Cardiac.
Barry Maron
Connection Strength
35.089
Death, Sudden, Cardiac
  1. Maron MS, Rowin EJ, Maron BJ. Letter by Maron et al Regarding Article, "Sudden Cardiac Death in National Collegiate Athletic Association Athletes". Circulation. 2024 Sep 17; 150(12):e255-e256.
    View in: PubMed
    Score: 0.704
  2. Harris KM, Mackey-Bojack S, Fisher G, Nwaudo D, Maron BJ. Arrhythmogenic Mitral Valve Prolapse Revisited: A Not Uncommon Cause of Youthful Sudden Death in Athletes and Women. Am J Med. 2025 Jan; 138(1):156-160.
    View in: PubMed
    Score: 0.700
  3. Maron BJ, Rowin EJ, Maron MS. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator. Heart Rhythm. 2021 06; 18(6):1012-1023.
    View in: PubMed
    Score: 0.547
  4. Harris KM, Mackey-Bojack S, Bennett M, Nwaudo D, Duncanson E, Maron BJ. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am J Cardiol. 2021 03 15; 143:131-134.
    View in: PubMed
    Score: 0.543
  5. Shirani J, Aurshiya R, Elshaikh A, Olenchock SA, Rowin EJ, Maron MS, Maron BJ. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices. Am J Cardiol. 2021 03 01; 142:130-135.
    View in: PubMed
    Score: 0.542
  6. Maron BJ, Estes NAM. The "Guidant Affair": 15 years later. Heart Rhythm. 2021 03; 18(3):487-488.
    View in: PubMed
    Score: 0.538
  7. Rowin EJ, Burrows A, Madias C, Estes NAM, Link MS, Maron MS, Maron BJ. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants. Circ Arrhythm Electrophysiol. 2020 10; 13(10):e008123.
    View in: PubMed
    Score: 0.533
  8. Maron BJ, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here? Am J Med. 2020 08; 133(8):886-888.
    View in: PubMed
    Score: 0.529
  9. Maron MS, Brush J, Rowin EJ, Maron BJ. Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoring. Heart Rhythm. 2021 01; 18(1):148-150.
    View in: PubMed
    Score: 0.528
  10. Rowin EJ, Sridharan A, Madias C, Firely C, Koethe B, Link MS, Maron MS, Maron BJ. Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 08 01; 128:75-83.
    View in: PubMed
    Score: 0.521
  11. Maron BJ, Mackey-Bojack S, Facile E, Duncanson E, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy. Am J Cardiol. 2020 07 15; 127:139-141.
    View in: PubMed
    Score: 0.519
  12. Maron BJ, Rowin EJ, Maron MS. Concerns About the HCM Risk-Kids Study. JAMA Cardiol. 2020 03 01; 5(3):362-363.
    View in: PubMed
    Score: 0.514
  13. Maron BJ, Harris KM, Maron MS. The Guidant Affair revisited?but this time with good news. Heart Rhythm. 2020 03; 17(3):512-513.
    View in: PubMed
    Score: 0.500
  14. Maron M, Rowin E, Maron BJ. Increasing evidence that risk scores underperform in predicting sudden death in hypertrophic cardiomyopathy. Heart. 2019 12; 105(24):1850-1851.
    View in: PubMed
    Score: 0.499
  15. Maron BJ, Rowin EJ, Maron MS. Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. Circ Res. 2019 08 02; 125(4):370-378.
    View in: PubMed
    Score: 0.494
  16. Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019 07 01; 4(7):644-657.
    View in: PubMed
    Score: 0.491
  17. Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, Ahmed A, Boriani G, Francia P, Winters SL, Giudici M, Koulova A, Garberich R, Rowin EJ, Sears SF, Maron MS, Spirito P. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol. 2018 04; 11(4):e005820.
    View in: PubMed
    Score: 0.450
  18. Maron BJ, Estes NAM, Maron MS. Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field? Am J Cardiol. 2018 04 15; 121(8):1008-1010.
    View in: PubMed
    Score: 0.445
  19. Rowin EJ, Maron MS, Chan RH, Hausvater A, Wang W, Rastegar H, Maron BJ. Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Dec 15; 120(12):2256-2264.
    View in: PubMed
    Score: 0.434
  20. Harris KM, Creswell LL, Haas TS, Thomas T, Tung M, Isaacson E, Garberich RF, Maron BJ. Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series. Ann Intern Med. 2017 Oct 17; 167(8):529-535.
    View in: PubMed
    Score: 0.434
  21. Maron BJ, Nishimura RA, Maron MS. Shared decision-making in HCM. Nat Rev Cardiol. 2017 03; 14(3):125-126.
    View in: PubMed
    Score: 0.415
  22. Maron BJ. Saving Lives One at a Time. JAMA Cardiol. 2016 07 01; 1(4):387-8.
    View in: PubMed
    Score: 0.399
  23. Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF. Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. Am J Med. 2016 Nov; 129(11):1170-1177.
    View in: PubMed
    Score: 0.392
  24. Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S. Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes? Am J Cardiol. 2016 Apr 15; 117(8):1339-41.
    View in: PubMed
    Score: 0.387
  25. Maron BJ, Maron MS. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. Heart Rhythm. 2016 05; 13(5):1155-1165.
    View in: PubMed
    Score: 0.385
  26. Maron BJ, Rowin EJ, Casey SA, Garberich RF, Maron MS. What Do Patients With Hypertrophic Cardiomyopathy Die from? Am J Cardiol. 2016 Feb 01; 117(3):434-5.
    View in: PubMed
    Score: 0.382
  27. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2343-2349.
    View in: PubMed
    Score: 0.381
  28. Semsarian C, Ingles J, Maron MS, Maron BJ. Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy? J Am Coll Cardiol. 2015 Oct 20; 66(16):1846-1847.
    View in: PubMed
    Score: 0.380
  29. Maron BJ. Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years. Am J Cardiol. 2015 Nov 01; 116(9):1461-8.
    View in: PubMed
    Score: 0.375
  30. Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Sep 01; 116(5):757-64.
    View in: PubMed
    Score: 0.370
  31. Maron BJ, Winkel BG, Tfelt-Hansen J. Cardiovascular screening for young athletes--reply. JAMA. 2015 Apr 28; 313(16):1674-5.
    View in: PubMed
    Score: 0.367
  32. Maron BJ. Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy. Card Electrophysiol Clin. 2015 Jun; 7(2):165-71.
    View in: PubMed
    Score: 0.366
  33. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015 Mar 31; 65(12):1249-1254.
    View in: PubMed
    Score: 0.365
  34. Maron BJ, Winkel BG, Tfelt-Hansen J. Perspectives on cardiovascular screening. JAMA. 2015 Jan 06; 313(1):31-2.
    View in: PubMed
    Score: 0.360
  35. Maron BJ, Weiner HL, Maron MS, Roberts WC. Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient. Am J Cardiol. 2015 Feb 01; 115(3):402-4.
    View in: PubMed
    Score: 0.356
  36. Maron BJ, Friedman R. To the editor--Participation screening for athletes. Heart Rhythm. 2014 Dec; 11(12):e199-200.
    View in: PubMed
    Score: 0.351
  37. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol. 2014 Apr 29; 63(16):1636-43.
    View in: PubMed
    Score: 0.339
  38. Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF. Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes. Int J Cardiol. 2014 May 15; 173(3):369-72.
    View in: PubMed
    Score: 0.339
  39. Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Apr 09; 61(14):1527-35.
    View in: PubMed
    Score: 0.319
  40. Maron BJ, Harris KM, Haas TS, Eichner ER. Reply: To PMID 22809753. Am J Cardiol. 2013 Jan 01; 111(1):149.
    View in: PubMed
    Score: 0.313
  41. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, Garberich RF, Lesser JR, Appelbaum E, Manning WJ, Maron MS. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age. Circulation. 2013 Feb 05; 127(5):585-93.
    View in: PubMed
    Score: 0.313
  42. Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC. Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm. 2013 Mar; 10(3):374-7.
    View in: PubMed
    Score: 0.311
  43. Maron BJ, Haas TS, Ahluwalia A, Garberich RF, Estes NA, Link MS. Increasing survival rate from commotio cordis. Heart Rhythm. 2013 Feb; 10(2):219-23.
    View in: PubMed
    Score: 0.309
  44. Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients. Heart Rhythm. 2013 Feb; 10(2):214-8.
    View in: PubMed
    Score: 0.308
  45. Harris KM, Haas TS, Eichner ER, Maron BJ. Sickle cell trait associated with sudden death in competitive athletes. Am J Cardiol. 2012 Oct 15; 110(8):1185-8.
    View in: PubMed
    Score: 0.303
  46. Maron BJ. Counterpoint/Mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012 Nov; 9(11):1897.
    View in: PubMed
    Score: 0.297
  47. Maron BJ. Counterpoint: Mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012 Oct; 9(10):1646-9.
    View in: PubMed
    Score: 0.296
  48. Maron BJ, Casey SA, Haas TS, Kitner CL, Garberich RF, Lesser JR. Hypertrophic cardiomyopathy with longevity to 90 years or older. Am J Cardiol. 2012 May 01; 109(9):1341-7.
    View in: PubMed
    Score: 0.295
  49. Maron BJ, Maron MS, Semsarian C. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. Heart Rhythm. 2012 Jan; 9(1):57-63.
    View in: PubMed
    Score: 0.284
  50. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ J. 2010 Nov; 74(11):2271-82.
    View in: PubMed
    Score: 0.268
  51. Maron BJ, Boren SD, Estes NA. Early descriptions of sudden cardiac death due to commotio cordis occurring in baseball. Heart Rhythm. 2010 Jul; 7(7):992-3.
    View in: PubMed
    Score: 0.260
  52. Maron BJ. Can sudden cardiac death be prevented? Cardiovasc Pathol. 2010 Nov-Dec; 19(6):329-35.
    View in: PubMed
    Score: 0.259
  53. Maron BJ. National electrocardiography screening for competitive athletes: Feasible in the United States? Ann Intern Med. 2010 Mar 02; 152(5):324-6.
    View in: PubMed
    Score: 0.257
  54. Maron BJ. Sudden cardiac death in genetic heart diseases and the promise of prevention. Rev Esp Cardiol. 2010 Mar; 63(3):257-60.
    View in: PubMed
    Score: 0.257
  55. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010 Jan 26; 121(3):445-56.
    View in: PubMed
    Score: 0.255
  56. Maron BJ. Dr. Gunnar Thor Gunnarsson and hypertrophic cardiomyopathy: what "giving back" means. Am J Cardiol. 2010 Jan 15; 105(2):277-8.
    View in: PubMed
    Score: 0.255
  57. Maron BJ. Sudden death in hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2009 Dec; 2(4):368-80.
    View in: PubMed
    Score: 0.252
  58. Maron BJ, Doerer JJ, Haas TS, Estes NA, Hodges JS, Link MS. Commotio cordis and the epidemiology of sudden death in competitive lacrosse. Pediatrics. 2009 Sep; 124(3):966-71.
    View in: PubMed
    Score: 0.247
  59. Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol. 2009 Jul 15; 104(2):276-80.
    View in: PubMed
    Score: 0.243
  60. Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J. 2009 Jul; 30(13):1627-34.
    View in: PubMed
    Score: 0.243
  61. Maron BJ, Spirito P. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr; 37(4):297-302.
    View in: PubMed
    Score: 0.241
  62. Spirito P, Autore C, Rapezzi C, Bernab? P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barill? CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009 Apr 07; 119(13):1703-10.
    View in: PubMed
    Score: 0.241
  63. Maron BJ, Spirito P. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008 Oct; 19(10):1118-26.
    View in: PubMed
    Score: 0.225
  64. Maron BJ, Zipes DP. It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports. Heart Rhythm. 2008 Jun; 5(6):864-6.
    View in: PubMed
    Score: 0.222
  65. Maron BJ. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin. 2007 Aug; 25(3):399-414, vi.
    View in: PubMed
    Score: 0.215
  66. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007 Jul 25; 298(4):405-12.
    View in: PubMed
    Score: 0.215
  67. Maron BJ. Hypertrophic cardiomyopathy in China. Am J Cardiol. 2007 Jul 01; 100(1):145-6.
    View in: PubMed
    Score: 0.212
  68. Adabag AS, Maron BJ. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol. 2007 Apr; 12(2):171-80.
    View in: PubMed
    Score: 0.210
  69. Doerer JJ, Haas TS, Estes NA, Link MS, Maron BJ. Evaluation of chest barriers for protection against sudden death due to commotio cordis. Am J Cardiol. 2007 Mar 15; 99(6):857-9.
    View in: PubMed
    Score: 0.207
  70. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. J Athl Train. 2007 Jan-Mar; 42(1):143-58.
    View in: PubMed
    Score: 0.206
  71. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006 Oct 10; 114(15):1633-44.
    View in: PubMed
    Score: 0.203
  72. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, Spataro A, Biffi A, Granata M, Maron BJ. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006 Sep; 27(18):2196-200.
    View in: PubMed
    Score: 0.200
  73. Maron BJ, Olivotto I, Maron MS. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators? Eur Heart J. 2006 Aug; 27(16):1895-7.
    View in: PubMed
    Score: 0.199
  74. Maron BJ, Doerer JJ, Haas TS, Estes NA, Link MS. Historical observation on commotio cordis. Heart Rhythm. 2006 May; 3(5):605-6.
    View in: PubMed
    Score: 0.197
  75. Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol. 2005 Oct 04; 46(7):1373-4.
    View in: PubMed
    Score: 0.189
  76. Hauser RG, Maron BJ. Lessons from the failure and recall of an implantable cardioverter-defibrillator. Circulation. 2005 Sep 27; 112(13):2040-2.
    View in: PubMed
    Score: 0.189
  77. Maron BJ, Wentzel DC, Zenovich AG, Estes NA, Link MS. Death in a young athlete due to commotio cordis despite prompt external defibrillation. Heart Rhythm. 2005 Sep; 2(9):991-3.
    View in: PubMed
    Score: 0.188
  78. Almquist AK, Montgomery JV, Haas TS, Maron BJ. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm. 2005 Aug; 2(8):814-9.
    View in: PubMed
    Score: 0.187
  79. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2005 Jul 15; 96(2):270-5.
    View in: PubMed
    Score: 0.186
  80. Gornick CC, Hauser RG, Almquist AK, Maron BJ. Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy. Heart Rhythm. 2005 Jul; 2(7):681-3.
    View in: PubMed
    Score: 0.186
  81. Maron BJ, Estes NA, Link MS. Task Force 11: commotio cordis. J Am Coll Cardiol. 2005 Apr 19; 45(8):1371-3.
    View in: PubMed
    Score: 0.183
  82. Link MS, Maron BJ. Sudden cardiac death caused by innocent chest wall blows. Ital Heart J. 2005 Apr; 6(4):281-3.
    View in: PubMed
    Score: 0.183
  83. Maron BJ. Ten common questions about hypertrophic cardiomyopathy...and misconceptions. Cardiol Rev. 2005 Mar-Apr; 13(2):59-60.
    View in: PubMed
    Score: 0.182
  84. Maron MS, Rowin EJ, Maron BJ. The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. Am J Cardiol. 2024 02 01; 212S:S64-S76.
    View in: PubMed
    Score: 0.169
  85. Maron BJ, Rowin EJ, Maron MS. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023. Am J Cardiol. 2024 02 01; 212S:S77-S82.
    View in: PubMed
    Score: 0.169
  86. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003 Sep 11; 349(11):1064-75.
    View in: PubMed
    Score: 0.164
  87. Maron MS, Mitten M, Borchers J, Rowin EJ, Maron BJ. Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease. J Am Coll Cardiol. 2023 08 29; 82(9):828-832.
    View in: PubMed
    Score: 0.163
  88. Maron BJ, Estes NAM, Rowin EJ, Maron MS, Reynolds MR. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023 07 25; 82(4):353-373.
    View in: PubMed
    Score: 0.163
  89. Maron BJ, Estes NAM. Commotio Cordis Returns?When We Least Expected It: Cardiac Arrest in A Professional Football Player. Am J Cardiol. 2023 09 01; 202:229-232.
    View in: PubMed
    Score: 0.163
  90. Maron MS, Rowin EJ, Bonaventura J, Maron BJ. Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field? Am J Cardiol. 2023 08 01; 200:236-238.
    View in: PubMed
    Score: 0.162
  91. Maron BJ, Estes NA, Maron MS, Almquist AK, Link MS, Udelson JE. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 2003 Jun 17; 107(23):2872-5.
    View in: PubMed
    Score: 0.161
  92. Maron MS, Rowin E, Spirito P, Maron BJ. Differing strategies for sudden death prevention in hypertrophic cardiomyopathy. Heart. 2023 03 27; 109(8):589-594.
    View in: PubMed
    Score: 0.159
  93. Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, Sherrid MV. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003 Mar 19; 41(6):974-80.
    View in: PubMed
    Score: 0.159
  94. Bonaventura J, Rowin EJ, Maron MS, Maron BJ. Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players. Am J Med. 2023 03; 136(3):315-321.
    View in: PubMed
    Score: 0.156
  95. Maron BJ. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Cardiol Rev. 2002 May-Jun; 10(3):173-81.
    View in: PubMed
    Score: 0.149
  96. Maron BJ, Gohman TE, Kyle SB, Estes NA, Link MS. Clinical profile and spectrum of commotio cordis. JAMA. 2002 Mar 06; 287(9):1142-6.
    View in: PubMed
    Score: 0.148
  97. Semsarian C, Maron BJ. Sudden cardiac death in the young. Med J Aust. 2002 Feb 18; 176(4):148-9.
    View in: PubMed
    Score: 0.147
  98. Maron BJ, Rowin EJ, Madias C, Dolan N, Maron MS. Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far). Am J Cardiol. 2022 04 01; 168:163-165.
    View in: PubMed
    Score: 0.147
  99. Maron BJ. The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification. Card Electrophysiol Rev. 2002 Feb; 6(1-2):100-3.
    View in: PubMed
    Score: 0.147
  100. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Dearani JA, Rowin EJ, Maron MS, Sherrid MV. Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 02 01; 79(4):390-414.
    View in: PubMed
    Score: 0.147
  101. Maron BJ, Mitten MJ, Greene Burnett C. Criminal consequences of commotio cordis. Am J Cardiol. 2002 Jan 15; 89(2):210-3.
    View in: PubMed
    Score: 0.146
  102. Rowin EJ, Maron MS, Adler A, Albano AJ, Varnava AM, Spears D, Marsy D, Heitner SB, Cohen E, Leong KMW, Winters SL, Martinez MW, Koethe BC, Rakowski H, Maron BJ. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study. Heart Rhythm. 2022 05; 19(5):782-789.
    View in: PubMed
    Score: 0.146
  103. Maron BJ, Link MS. Don't Forget Commotio Cordis. Am J Cardiol. 2021 10 01; 156:134-135.
    View in: PubMed
    Score: 0.142
  104. Maron BJ, Rowin EJ, Maron MS. After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease With Low Mortality and Morbidity, But is This Paradigm Under-Recognized in the Literature? Am J Cardiol. 2021 03 01; 142:136-137.
    View in: PubMed
    Score: 0.136
  105. Maron MS, Steiger N, Burrows A, Madias C, Weinstock J, Link MS, Rowin EJ, Maron BJ. Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2020 08; 6(8):1019-1021.
    View in: PubMed
    Score: 0.132
  106. Maron MS, Rowin EJ, Maron BJ. Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy? Trends Cardiovasc Med. 2021 01; 31(1):32-33.
    View in: PubMed
    Score: 0.127
  107. Thiene G, Rizzo S, Schiavon M, Maron MS, Zorzi A, Corrado D, Maron BJ, Basso C. Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People. J Am Coll Cardiol. 2019 06 18; 73(23):3031-3032.
    View in: PubMed
    Score: 0.122
  108. Cooper S, Woodford NW, Maron BJ, Harris KM, Sheppard MN. A Lethal Blow to the Chest as an Underdiagnosed Cause of Sudden Death in United Kingdom Sports (Football, Cricket, Rugby). Am J Cardiol. 2019 09 01; 124(5):808-811.
    View in: PubMed
    Score: 0.122
  109. Maron BJ. Clinical Course and Management of Hypertrophic Cardiomyopathy. N Engl J Med. 2018 Aug 16; 379(7):655-668.
    View in: PubMed
    Score: 0.115
  110. Maron BJ, Rowin EJ, Maron MS. Global Burden of Hypertrophic?Cardiomyopathy. JACC Heart Fail. 2018 05; 6(5):376-378.
    View in: PubMed
    Score: 0.113
  111. Rowin EJ, Maron BJ, Abt P, Kiernan MS, Vest A, Costantino F, Maron MS, DeNofrio D. Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 04 15; 121(8):986-996.
    View in: PubMed
    Score: 0.111
  112. Maron MS, Rowin EJ, Maron BJ. How to Image Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 07; 10(7).
    View in: PubMed
    Score: 0.107
  113. Wang W, Lian Z, Rowin EJ, Maron BJ, Maron MS, Link MS. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.104
  114. Konstantinou DM, Efthimiadis GK, Vassilikos V, Paraskevaidis S, Pagourelias E, Maron BJ, Karvounis H. Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2016 Jun; 17(6):433-9.
    View in: PubMed
    Score: 0.099
  115. Lynge TH, Risgaard B, Jabbari R, Glinge C, Bundgaard H, Maron B, Hauns? S, Winkel BG, Tfelt-Hansen J. Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark. Europace. 2016 Dec; 18(12):1801-1808.
    View in: PubMed
    Score: 0.097
  116. Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS. Hypertrophic Cardiomyopathy in?Adulthood Associated With Low?Cardiovascular Mortality With Contemporary Management Strategies. J Am Coll Cardiol. 2015 May 12; 65(18):1915-28.
    View in: PubMed
    Score: 0.092
  117. Maron BJ, Friedman RA, Caplan A. Ethics of preparticipation cardiovascular screening for athletes. Nat Rev Cardiol. 2015 Jun; 12(6):375-8.
    View in: PubMed
    Score: 0.091
  118. Maron BJ, Nishimura RA. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Circulation. 2014 Oct 28; 130(18):1617-24.
    View in: PubMed
    Score: 0.089
  119. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014 Aug 05; 130(6):484-95.
    View in: PubMed
    Score: 0.087
  120. Quattrini FM, Pelliccia A, Assorgi R, DiPaolo FM, Squeo MR, Culasso F, Castelli V, Link MS, Maron BJ. Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes. Heart Rhythm. 2014 Nov; 11(11):1974-82.
    View in: PubMed
    Score: 0.087
  121. Spirito P, Autore C, Formisano F, Assenza GE, Biagini E, Haas TS, Bongioanni S, Semsarian C, Devoto E, Musumeci B, Lai F, Yeates L, Conte MR, Rapezzi C, Boni L, Maron BJ. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors. Am J Cardiol. 2014 May 01; 113(9):1550-5.
    View in: PubMed
    Score: 0.084
  122. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013 Jan 19; 381(9862):242-55.
    View in: PubMed
    Score: 0.076
  123. Chung WK, Kitner C, Maron BJ. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death. Cardiol Young. 2011 Jun; 21(3):345-8.
    View in: PubMed
    Score: 0.068
  124. Maron BJ. The 2009 international hypertrophic cardiomyopathy summit. Am J Cardiol. 2010 Apr 15; 105(8):1164-8.
    View in: PubMed
    Score: 0.064
  125. Sherrid MV, Cotiga D, Hart D, Ehlert F, Haas TS, Shen WK, Link MS, Estes NA, Epstein AE, Semsarian C, Daubert JP, Winters SL, Giudici MC, Maron BJ. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy. Am J Cardiol. 2009 Dec 15; 104(12):1722-6.
    View in: PubMed
    Score: 0.063
  126. Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, Seidman J, Seidman CE. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009 Mar 25; 301(12):1253-9.
    View in: PubMed
    Score: 0.060
  127. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Heart Rhythm. 2008 Oct; 5(10):e1-21.
    View in: PubMed
    Score: 0.058
  128. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol. 2008 Sep 30; 52(14):1179-99.
    View in: PubMed
    Score: 0.058
  129. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008 Sep 30; 118(14):1497-1518.
    View in: PubMed
    Score: 0.058
  130. Maron BJ. Medical data, the media, and distortion of the facts in the internet era. Am J Cardiol. 2008 Mar 15; 101(6):890-1.
    View in: PubMed
    Score: 0.056
  131. Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, De Luca R, Spataro A, Biffi A, Thiene G, Maron BJ. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008 Jan 10; 358(2):152-61.
    View in: PubMed
    Score: 0.055
  132. Friedewald VE, Maron BJ, Roberts WC. The editor's roundtable: sudden cardiac death in athletes. Am J Cardiol. 2007 Nov 01; 100(9):1451-9.
    View in: PubMed
    Score: 0.055
  133. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Prehosp Emerg Care. 2007 Jul-Sep; 11(3):253-71.
    View in: PubMed
    Score: 0.053
  134. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation. 2007 May 01; 115(17):2358-68.
    View in: PubMed
    Score: 0.053
  135. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007 Mar 27; 115(12):1643-455.
    View in: PubMed
    Score: 0.052
  136. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Heart Rhythm. 2007 Apr; 4(4):549-65.
    View in: PubMed
    Score: 0.052
  137. Madias C, Maron BJ, Weinstock J, Estes NA, Link MS. Commotio cordis--sudden cardiac death with chest wall impact. J Cardiovasc Electrophysiol. 2007 Jan; 18(1):115-22.
    View in: PubMed
    Score: 0.052
  138. Stout CW, Maron BJ, Vanderbrink BA, Estes NA, Link MS. Importance of the autonomic nervous system in an experimental model of commotio cordis. Med Sci Monit. 2007 Jan; 13(1):BR11-5.
    View in: PubMed
    Score: 0.051
  139. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006 Dec 01; 98(11):1507-11.
    View in: PubMed
    Score: 0.051
  140. Weinstock J, Maron BJ, Song C, Mane PP, Estes NA, Link MS. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics. 2006 Apr; 117(4):e656-62.
    View in: PubMed
    Score: 0.049
  141. Salib EA, Cyran SE, Cilley RE, Maron BJ, Thomas NJ. Efficacy of bystander cardiopulmonary resuscitation and out-of-hospital automated external defibrillation as life-saving therapy in commotio cordis. J Pediatr. 2005 Dec; 147(6):863-6.
    View in: PubMed
    Score: 0.048
  142. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Apr 19; 45(8):1251-8.
    View in: PubMed
    Score: 0.046
  143. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol. 2005 Apr 19; 45(8):1318-21.
    View in: PubMed
    Score: 0.046
  144. Garan AR, Maron BJ, Wang PJ, Estes NA, Link MS. Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis). J Cardiovasc Electrophysiol. 2005 Apr; 16(4):433-8.
    View in: PubMed
    Score: 0.046
  145. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Mar 01; 45(5):697-704.
    View in: PubMed
    Score: 0.045
  146. Boriani G, Maron BJ, Shen WK, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation. 2004 Oct 12; 110(15):e438-42.
    View in: PubMed
    Score: 0.044
  147. Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am. 2004 Oct; 51(5):1305-46.
    View in: PubMed
    Score: 0.044
  148. Maron BJ, Chaitman BR, Ackerman MJ, Bay?s de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA, Ara?jo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004 Jun 08; 109(22):2807-16.
    View in: PubMed
    Score: 0.043
  149. Bonaventura J, Rowin EJ, Chan RH, Chin MT, Puchnerova V, Polakova E, Macek M, Votypka P, Batorsky R, Perera G, Koethe B, Veselka J, Maron BJ, Maron MS. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2024 May 21; 13(10):e033565.
    View in: PubMed
    Score: 0.043
  150. Basso C, Fox PR, Meurs KM, Towbin JA, Spier AW, Calabrese F, Maron BJ, Thiene G. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation. 2004 Mar 09; 109(9):1180-5.
    View in: PubMed
    Score: 0.042
  151. Carrick RT, Ahamed H, Sung E, Maron MS, Madias C, Avula V, Studley R, Bao C, Bokhari N, Quintana E, Rajesh-Kannan R, Maron BJ, Wu KC, Rowin EJ. Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach. Heart Rhythm. 2024 08; 21(8):1390-1397.
    View in: PubMed
    Score: 0.042
  152. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 05; 42(9):1687-713.
    View in: PubMed
    Score: 0.041
  153. Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003 Sep 03; 42(5):882-8.
    View in: PubMed
    Score: 0.041
  154. Wang RS, Rowin EJ, Maron BJ, Maron MS, Maron BA. A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification. Cardiovasc Res. 2023 05 02; 119(3):e125-e127.
    View in: PubMed
    Score: 0.040
  155. Maron BJ, Piccininno M, Casey SA, Bernab? P, Spirito P. Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy. Am J Cardiol. 2003 Mar 01; 91(5):626-8.
    View in: PubMed
    Score: 0.040
  156. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003 Jan 23; 348(4):295-303.
    View in: PubMed
    Score: 0.039
  157. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003 Jan; 24(1):13-5.
    View in: PubMed
    Score: 0.039
  158. Link MS, Maron BJ, Wang PJ, VanderBrink BA, Zhu W, Estes NA. Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis). J Am Coll Cardiol. 2003 Jan 01; 41(1):99-104.
    View in: PubMed
    Score: 0.039
  159. Maron BJ. Cardiology patient pages. Hypertrophic cardiomyopathy. Circulation. 2002 Nov 05; 106(19):2419-21.
    View in: PubMed
    Score: 0.039
  160. Abdelfattah OM, Martinez M, Sayed A, ElRefaei M, Abushouk AI, Hassan A, Masri A, Winters SL, Kapadia SR, Maron BJ, Rowin E, Maron MS. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2022 11; 8(11):1417-1427.
    View in: PubMed
    Score: 0.038
  161. Link MS, Maron BJ, Wang PJ, Pandian NG, VanderBrink BA, Estes NA. Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics. 2002 May; 109(5):873-7.
    View in: PubMed
    Score: 0.037
  162. Sridharan A, Maron MS, Carrick RT, Madias CA, Huang D, Cooper C, Drummond J, Maron BJ, Rowin EJ. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2022 01; 33(1):20-29.
    View in: PubMed
    Score: 0.036
  163. Papanastasiou CA, Zegkos T, Karamitsos TD, Rowin EJ, Maron MS, Parcharidou D, Kokkinidis DG, Karvounis H, Rimoldi O, Maron BJ, Efthimiadis GK. Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis. Int J Cardiol. 2021 06 01; 332:127-132.
    View in: PubMed
    Score: 0.035
  164. Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1027-32.
    View in: PubMed
    Score: 0.019
  165. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bj?rnstad HH, Carr? F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010 Jan; 31(2):243-59.
    View in: PubMed
    Score: 0.016
  166. Biffi A, Maron BJ, Verdile L, Fernando F, Spataro A, Marcello G, Ciardo R, Ammirati F, Colivicchi F, Pelliccia A. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2004 Sep 01; 44(5):1053-8.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.